The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Clinical trial NCT03460808 · UNKNOWN
Trial details
- NCT number
- NCT03460808
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-10
- Primary completion
- 2020-01-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.